Invest in Spain Aragón

Phone-alt Envelope

Menu

Day: May 18, 2022

Categories
Pharmaceutical

The world’s leading company in hormonal therapies, Besins Healthcare, installs its newest factory in Aragon

Aragon attracts another pharmaceutical company to install its first factory in Spain
The 25-million-euro investment will create 150 highly qualified jobs

Besins Healthcare, world leadeing company in novel therapies for gynecology, fertility, obstetrics, endocrinology and andrology, has chosen the town of Muel (Zaragoza) to install its first factory in Spain. The pharmaceutical multinational acquired a 9,800-square-meter warehouse in the industrial area El Pitarco to carry out this investment, which will reach 25 million euros and create 150 stable highly qualified jobs.

The plant is expected to start manufacturing in the second half of 2022. Construction works are already underway, soon part of the equipment will be installed so that it can be tested starting this summer. According to company sources, there could be additional future investments, “given that we are talking about a stable process of decades.” Besins has assured that, as a company in a constant research process, they contemplate the production of new creation products at the Muel plant destined for the whole world.

This new business project will be declared of Regional Interest by the Government of Aragon, which will make it possible to shorten administrative process times. In addition to this declaration, the Department of Economy, Planning and Employment is already processing, together with the company, its application file for Regional Economic Incentives. The President of Aragon, Javier Lambán, declared that this investment is particularly welcome as it is implanted in a rural area, contributing to its revitalization.

Why did Besins choose Aragon?

Besins Healthcare has chosen Aragon to install its first plant in Spain due to factors such as its geographical location and communication routes. In addition, the proximity of Muel to the University of Zaragoza facilitates the hiring or attraction of qualified personnel. Another decisive cause that has led the managers of the company to settle in Muel is the immediate availability of a spacious and empty warehouse that allows, in a short time, the integration of all the necessary facilities for the production of medicines. 

Besides, according to the president of the French company, Antoine Besins, choosing Aragon has responded to objective industrial parameters. Although, among all the candidate countries -mandatorily belonging to the European Union for the application of mandatory pharmaceutical standards-, the “excellent” reception of the authorities and the facilities for the establishment of companies in the sector has entailed a keypoint to make this decision.

The Department of Economy, Planning and Employment, through Aragón Exterior (AREX), began working in 2019 on attracting the investment project of this company. Up to 14 Autonomous Communities presented location proposals in their territory. Germany, the Netherlands, Belgium or Ireland have competed with Spain, and within Spain, Aragón was the most competitive region for its dynamism and adaptation to the needs of the company. 

A leading company

Besins Healthcare is a family business specialized in the development and commercialization of hormonal therapies for the treatment of gynecology and obstetrics, fertility, endocrinology and andrology. It currently produces and markets more than thirty different products that are prescribed in one hundred countries around the world.

One of the mainstays of the company is constant research. Thanks to it, it has been possible to discover innovative technologies that have an impact on improving the health of women and men throughout their lives. Besins Healthcare products include natural progesterone for pregnant women, transdermal gel for testosterone deficiency syndrome, or estradiol replacement therapies during menopause.

Source: Aragonhoy

Categories
Automotive Sin categoría

Magna will invest 15 million euros and create 50 new jobs backed by aid for R&D from the Government of Aragon

Magna Automotive expands its production in Aragon boosting their line of electric vehicles
Aragon consolidates its commitment to R&D subsidizing 28 new business projects that promoted an investment of 60 million euros

Magna Automotive will invest 15 million euros in its Pedrola plant over the next two years, which will be allocated mainly to new production lines for components for electric vehicles and the improvement of current processes, supported by aid for R&D in mobility of the Department of Economy, Planning and Employment of the Government of Aragon. With these projects under development and other products in the launch phase, the company expects to generate 50 new jobs.

Magna Automotive has been awarded a total of nearly 1.2 million euros through the two calls for R&D grants aimed at the automotive sector launched to date by the Department of Economy. The last of them, published last year, has made it possible to support one of Magna’s experimental development projects and ten other business proposals linked to sustainable mobility, in addition to four business initiatives in the pharmaceutical sector and 13 in the circular economy. These 28 subsidized business R&D projects in 2021 have made it possible to promote an investment of 60 million euros in Aragon.

In 2019, the Department of Economy had convened for the first time this type of R&D aid aimed exclusively at the development of the electric vehicle, subsidizing another nine different projects that have generated an investment of 53.9 million euros in Aragon. In that first call, Magna received a grant to create a hot stamping battery tray for electric vehicles.

The company has thanked the Government of Aragon for its support in their current and future plans which reinforces the commitment to the territory, people and industry as an economic engine for development.

Producing in Aragon since 2016

The Magna group is one of the main suppliers in the automotive sector, being a leading company in the use of technology and offering advanced solutions to facilitate mobility. Globally, the company has more than 161,000 employees and an organizational structure designed to innovate and adapt with agility. Magna’s 60 years of experience are supported by a unique systems approach for design, engineering and manufacturing that encompasses most vehicle components. Their global network includes 340 manufacturing operations and 89 sales, engineering and product development centers in 28 countries. The company is committed to a business model based on long-term sustainability and integrates Corporate Social responsibility policies into its processes.

After managing its implementation in our Autonomous Community with the support of Aragón Exterior / Invest in Aragon, this Magna division has been operating in Pedrola since 2016. At this time, the plant is focused on the manufacture of components for vehicle bodywork with a high level of automation and has a workforce of more than 300 people. The company expects to reach a turnover of close to 75 million euros in 2022 due to the specialization in hot stamping processes, laser cutting and assembly of parts through resistance welding and MIG/MAG. Components are served to the main automobile manufacturers, not only in Spain but also in several European countries.

As a complement to its productive work and to give greater impetus to its innovation and development activities, the company has been working for several years with the University of Zaragoza and has its own Collaboration Chair. The commitment to local talent and internal development has allowed the company to consolidate a high-level production and technical team through specific qualification programs.

Source: Aragonhoy